NMN (Nicotinamide Mononucleotide): The Complete Ingredient Guide
NMN is a naturally occurring molecule that your body uses to make NAD+. NAD+ is the fuel behind your cells' ability to repair, recover, and produce energy. The problem is that NAD+ levels fall sharply as you age. NMN is the most direct way to top them back up.
This page covers the science: what NMN is, how it works, what the clinical research actually shows, and how to take it. No hype. No overclaiming. Just the biochemistry.
What Is NMN?
NMN stands for nicotinamide mononucleotide. It is a nucleotide, which means it belongs to the same chemical family as the building blocks of DNA and RNA. Your body makes NMN naturally, and it is found in small amounts in food: edamame, broccoli, avocado, cucumber. The amounts in food are too small to move the needle on NAD+ in any meaningful way, which is why supplementation exists.
NMN's primary job in the body is to act as a direct precursor to NAD+ (nicotinamide adenine dinucleotide). Think of NMN as the raw material your cells use to build one of the most critical molecules in human biology. Understanding what NMN is at a biochemical level makes the rest of the science a lot easier to follow.
NMN is not a drug. It is a molecule your body already produces and uses. The question is how much of it you have access to, and that changes substantially as you get older.
How NMN Raises NAD+
Your cells make NAD+ through several pathways. The one that matters most for supplementation is called the salvage pathway. This is the recycling system your body uses to recover and rebuild NAD+ from precursor molecules rather than synthesising it from scratch.
NMN sits one step away from NAD+ in this pathway. Once NMN enters a cell, the enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase) converts it directly to NAD+. That conversion is fast. No additional steps required between NMN and the final molecule.
Contrast that with tryptophan or niacin, which feed into NAD+ synthesis from much further upstream. More steps means more opportunity for the process to bottleneck, particularly in ageing cells where enzyme activity is already lower.
For NMN to work, it first needs to get into cells. Research from Washington University in St. Louis identified a specific transporter called Slc12a8 that moves NMN directly across the cell membrane. This was a significant finding because it answered a longstanding question about whether NMN could survive long enough in circulation to reach cells intact. The short answer is: yes, at least in part.
The net result is measurable. Multiple human trials have confirmed that oral NMN supplementation raises blood NAD+ levels. Whether those elevated levels translate into the functional benefits seen in animal studies is the focus of ongoing research.
Why NAD+ Declines With Age
NAD+ decline is one of the better-characterised hallmarks of ageing. By the time you reach your 40s or 50s, NAD+ levels in most tissues are roughly half what they were in your 20s. In some tissues, the drop is steeper.
Several things drive this. First, the enzymes that consume NAD+ become more active with age. SIRTs (sirtuins) and PARPs (poly ADP-ribose polymerases) both use NAD+ as a substrate. PARPs in particular are activated by DNA damage, which accumulates over time. So the older your cells, the more NAD+ they burn through trying to repair themselves, and the less is left over for everything else.
Second, CD38 activity increases with age. CD38 is an enzyme that degrades NAD+ and is also upregulated by chronic low-grade inflammation, which is common in older adults. This accelerates the depletion further.
Third, the production side weakens. The salvage pathway becomes less efficient as cells age, so the body gets worse at replenishing NAD+ at the same rate it uses it.
The consequences are not trivial. NAD+ is required for:
- Mitochondrial energy production (the electron transport chain runs on it)
- DNA damage repair via PARP activation
- Sirtuin-mediated gene regulation and stress response
- Cellular metabolism, including glucose and fatty acid processing
When NAD+ falls, none of these processes work as well. The link between NAD+ decline and the broader biology of ageing is now well-established in the scientific literature, even if the clinical implications in humans are still being worked out.
NMN Benefits: What the Research Shows
Most of the landmark NMN research has been done in mice, and mouse studies are not human studies. That caveat matters. What follows is a summary of where the human evidence currently stands, alongside the animal data that shaped the hypotheses researchers are now testing in clinical trials.
Energy and Mitochondrial Function
A 2022 randomised, double-blind, placebo-controlled trial published in npj Aging (Igarashi et al.) found that 250mg of NMN per day for 12 weeks significantly increased blood NAD+ levels in older adults and improved measures of physical performance, including grip strength and walking speed. The effect was most pronounced in participants whose NAD+ had been lowest at baseline.
Mitochondria use NAD+ to run the electron transport chain. Animal studies consistently show that restoring NAD+ in aged animals improves mitochondrial function and energy output. Human trials are beginning to show signals in the same direction, though larger studies are needed.
DNA Repair and Cellular Resilience
PARPs consume large amounts of NAD+ when repairing DNA strand breaks. If NAD+ is depleted, PARP activity slows, damage accumulates, and cells are more likely to enter senescence or apoptosis. Supplementing NMN to restore NAD+ availability theoretically keeps this repair system better resourced. This has been demonstrated in mouse models of accelerated ageing. Direct human evidence on DNA repair rates is limited but actively being studied.
Cardiovascular Health
A trial by Yoshino et al. (2021, Science) in postmenopausal women with prediabetes found that 250mg of NMN daily for 10 weeks improved muscle insulin sensitivity and increased expression of genes involved in muscle remodelling. Cardiovascular endpoints were not the primary focus, but metabolic improvements often correlate with cardiovascular benefit.
Animal studies have shown NMN preserves vascular elasticity and blood flow in aged mice. Human cardiovascular data is still emerging.
Metabolic Health
The Yoshino trial is the strongest human signal here. Improved insulin sensitivity in skeletal muscle is a meaningful metabolic outcome, particularly for middle-aged and older adults at risk of type 2 diabetes. Separately, a 2022 trial (Yi et al.) in healthy adults found NMN improved muscle metabolism and physical capacity in men over 65.
For a fuller look at NMN benefits across the current clinical literature, including study details and effect sizes, see the dedicated research summary.
NMN and Longevity
The longevity angle on NMN is real but often overstated. Here is what the science actually shows, and where the lines between animal data and human reality still need to be drawn.
Sirtuins
Sirtuins (SIRT1-7 in humans) are NAD+-dependent enzymes that regulate gene expression, DNA repair, mitochondrial function, and stress response. They were identified as key mediators of longevity in yeast and later in mammals, largely through the work of David Sinclair at Harvard and Leonard Guarente at MIT.
The core insight: sirtuins need NAD+ to work. No NAD+, no sirtuin activity. Restoring NAD+ via NMN reactivates sirtuins in aged tissue. In mice, this has been shown to reverse several markers of ageing in muscle, liver, and the vascular system. In humans, sirtuin activation via NAD+ restoration is plausible and consistent with the available data, but direct evidence of longevity extension does not yet exist.
mTOR and AMPK
NAD+ and NMN sit at a junction with other longevity-associated pathways. AMPK (activated by low energy states) and mTOR (involved in cell growth and nutrient sensing) both interact with NAD+ metabolism. SIRT1 can inhibit mTOR signalling, and AMPK activation is associated with longer lifespan in multiple animal models. NMN's role in this network is one reason researchers consider it a candidate for longevity support, not just energy or metabolism. The mechanistic connections are real. The clinical longevity data in humans is not yet there.
What Sinclair and Guarente Actually Said
Both researchers have been clear that their mouse data is compelling but that human translation takes time. Sinclair has noted he personally takes NMN as part of a broader longevity stack, which is a personal decision based on the mechanistic rationale, not a claim that it extends human lifespan. That distinction matters. The science supports the rationale. It does not yet support headlines about reversing ageing.
NMN vs NR
NR (nicotinamide riboside) and NMN are both NAD+ precursors and are often compared. Both raise NAD+ levels in humans. The differences are worth understanding.
The biosynthetic pathway goes: NR converts to NMN, then NMN converts to NAD+. NMN is one step closer to NAD+ than NR. That sounds like a clear win for NMN, but biology is not always that straightforward.
Some research suggests that in certain tissues, NR may actually be absorbed more readily, convert to NMN intracellularly, and reach NAD+ from there. The discovery of the Slc12a8 transporter for NMN changed the picture somewhat, suggesting NMN has its own direct uptake route in at least some tissues, particularly the intestine and possibly muscle.
Head-to-head human trials comparing NMN and NR on the same outcomes are limited. What exists suggests both raise blood NAD+ levels, with some variation in magnitude and tissue distribution depending on the study design and dose.
Bioavailability data from a 2023 pharmacokinetic trial (Irie et al.) found that oral NMN raised plasma NMN and NAD+ metabolites within 2-3 hours of ingestion, with a dose-dependent response. Similar pharmacokinetic profiles have been shown for NR.
The practical difference for most people is probably smaller than the marketing around both supplements suggests. NMN is the more direct precursor. Whether that translates to meaningfully different outcomes at typical supplement doses is still being studied. For a detailed side-by-side, see the full NMN vs NR breakdown.
NMN Dosage: How Much to Take
The clinical research on NMN has used doses ranging from 250mg to 1,000mg per day. Most human trials have used 250mg-500mg, which is where the bulk of the safety and efficacy data sits.
The 500mg dose is the most studied in adults over 40 and is the dose in the NMN Bio formula. There is no strong evidence that going above 500mg per day delivers proportionally greater benefit for most people, though individual variation exists.
Timing matters less than consistency, but most users take NMN in the morning. NAD+ is involved in circadian rhythm regulation, and there is some evidence that morning dosing aligns better with the body's natural NAD+ fluctuation across the day. Taking it with or without food appears to make little difference to absorption based on available data.
For full context on dose selection and timing, see the dedicated NMN dosage guide.
NMN and TMG: Why They're Taken Together
This is biochemistry, not marketing. The reason NMN and TMG are often taken together comes down to methylation.
When NMN raises NAD+ levels, NAD+ gets used by sirtuins and other enzymes. One byproduct of sirtuin activity is nicotinamide, which the body needs to clear through a process called methylation. Methylation requires methyl groups. The main methyl donor in this process is SAM (S-adenosylmethionine).
If you are producing a lot of NAD+ and cycling through it rapidly, you increase the demand for methyl groups. If methyl groups run short, the body draws on reserves that are also needed for other methylation reactions, including DNA methylation, neurotransmitter synthesis, and liver detoxification.
TMG (trimethylglycine, also called betaine) donates methyl groups. Taking it alongside NMN gives the body the methylation capacity to clear nicotinamide efficiently without depleting other methyl group pools.
Not everyone taking NMN will need TMG. People with sufficient dietary intake of methyl donors (folate, B12, choline) may manage fine without it. But for those taking NMN consistently, particularly at 500mg or above, TMG is a sensible addition based on the underlying biochemistry.
For everything on TMG, its mechanisms, and the research behind it, see the TMG ingredient guide.
NMN Side Effects
NMN is well-tolerated in the doses studied in clinical trials. Most participants in human trials report no significant side effects at 250mg-500mg per day.
At higher doses (750mg-1,000mg), a small number of people report mild nausea, particularly when taken on an empty stomach. This is uncommon and typically resolves by taking NMN with food or reducing the dose.
There is no clinical data on NMN use during pregnancy or breastfeeding, so it should be avoided during those periods out of caution. People on medication for diabetes or cardiovascular conditions should check with a clinician before starting, since NMN can affect insulin sensitivity and blood pressure in ways that may interact with treatment.
For a full breakdown of what the clinical trials report, see the NMN side effects page.
The NMN Bio Formula
NMN Bio's NMN 500mg capsules contain 500mg of pharmaceutical-grade NMN per capsule. Each batch is third-party tested for purity and potency. No fillers. No proprietary blends. Just the active ingredient at the dose used in human clinical research.
The formula is available on its own or as part of the Morning Bundle, which pairs NMN 500 with TMG for the methylation support described above.
Your ageing, your rules.
